(DLQI) a validated questionnaire designed by Finlay in 1994 to assess the impact of skin diseases on psychological and social wellbeing. It is the most common *quality of life tool used as an endpoint in dermatology clinical trials. DLQI scores of more than 10 (indicating a severe impact on life) are required before biological treatments for psoriasis may be administered in the UK.... dermatology life quality index
(PASI) a semiobjective severity score for psoriasis, including measurement of surface area affected and the degree of erythema, induration, and scale. It is commonly used in clinical trials and to ration expensive treatments for psoriasis. Severe disease equates to scores over 10 and it is often interpreted with the *dermatology life quality index (DLQI) score.... psoriasis area severity index
Health Encyclopedia